Unknown

Dataset Information

0

KDM3B suppresses APL progression by restricting chromatin accessibility and facilitating the ATRA-mediated degradation of PML/RAR?.


ABSTRACT: Background:A hallmark of acute promyelocytic leukemia (APL) is the expression of PML/RAR? fusion protein. Treatment with all-trans retinoic acid (ATRA) results in the terminal differentiation of neutrophil granulocytes. However, the underlying mechanisms remain largely unknown. Here, we identify and elucidate a novel differentiation-suppressive model of APL involving the histone demethylase KDM3B, which has been identified as a suppressor of the tumor genes involved in hematopoietic malignancies. Methods:First, we established a KDM3B knockdown NB4 cell model to determine the functional characteristics of KDM3B by cell proliferation assay and flow cytometry. Then, we performed ChIP-seq and ATAC-seq to search for potential relationships among KDM3B, histone modification (H3K9me1/me2) and the chromatin state. Finally, molecular biological techniques and a multi-omics analysis were used to explore the role of KDM3B in differentiation of the leukemia cells after ATRA treatment. Results:We found that knocking down KDM3B contributed to the growth of NB4 APL cells via the promotion of cell-cycle progression and blocked granulocytic differentiation. Through global and molecular approaches, we provided futher evidence that knocking down KDM3B altered the global distribution of H3K9me1/me2 and increased the chromatin accessibility. Moreover, knocking down KDM3B inhibited the ATRA-induced degradation of the PML/RAR? oncoprotein. Conclusion:Our study suggested that KDM3B was able to inhibit APL progression by maintaining chromatin in a compact state and facilitating the ATRA-mediated degradation of PML/RAR?. Taken together, the results show that KDM3B may be an alternative target for the treatment regimens and the targeted therapy for APL by sustaining the function of PML/RAR? fusion protein.

SUBMITTER: Wang X 

PROVIDER: S-EPMC6778369 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

KDM3B suppresses APL progression by restricting chromatin accessibility and facilitating the ATRA-mediated degradation of PML/RARα.

Wang Xinrui X   Fan Huiyong H   Xu Congling C   Jiang Guojuan G   Wang Haiwei H   Zhang Ji J  

Cancer cell international 20191004


<h4>Background</h4>A hallmark of acute promyelocytic leukemia (APL) is the expression of PML/RARα fusion protein. Treatment with all-trans retinoic acid (ATRA) results in the terminal differentiation of neutrophil granulocytes. However, the underlying mechanisms remain largely unknown. Here, we identify and elucidate a novel differentiation-suppressive model of APL involving the histone demethylase KDM3B, which has been identified as a suppressor of the tumor genes involved in hematopoietic mali  ...[more]

Similar Datasets

2020-04-10 | GSE137105 | GEO
2020-04-10 | GSE137104 | GEO
2020-04-10 | GSE137103 | GEO
| PRJNA564552 | ENA
| PRJNA564558 | ENA
| PRJNA564557 | ENA
| S-EPMC7212609 | biostudies-literature
| S-EPMC3868189 | biostudies-literature
| S-EPMC3494703 | biostudies-literature
| S-EPMC10928094 | biostudies-literature